Search Within

Neil Mukund Iyengar

  1. "Mark Robson"
Formats
  1. Meeting Abstract (8)
Groups
  1. Breast Medicine Service (8)
  2. Department of Medicine (8)
  3. Population Sciences Research Program (8)
  4. Solid Tumor Oncology Division (8)
  5. Survivorship Research (8)
  6. Nursing (6)

More Groups

People
  1. Mark Robson (8)
  2. Andrea Smith (5)
  3. Stacie Corcoran (5)
  4. Bridget Kelly (4)
  5. Jill Ainbinder (4)
  6. John Russell (3)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (2)
Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer Research (1)
  3. Medicine and Science in Sports and Exercise (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (1)
  3. Lippincott Williams & Wilkins (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction
    Meeting Abstract

    Shen, S.; Solomon, V.; Williams, D.; Robson, M. E.; Norton, L.; Traina, T. A.; Iyengar, N. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Early integration of exercise into breast cancer care: The MSK healthy living program
    Meeting Abstract

    Rowed, K.; Shen, S.; Smith, A.; Kelly, B.; Magnoli, R.; Corcoran, S.; Emerzian, M.; Ackerman, K.; Cruz, C.; Salehi, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor-positive breast cancer
    Meeting Abstract

    Lacouture, M. E.; Pan, A.; Dranitsaris, G.; Harris, U.; Chandarlapaty, S.; Dang, C. T.; Gajria, D.; Gordon, A.; Iyengar, N. M.; Robson, M. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The Optimal Living Program: Integrating exercise into cancer care
    Meeting Abstract

    Rowed, K.; Shen, S.; Corcoran, S.; Clayton, J.; Kelly, B.; Smith, A.; Emerzian, M.; Cruz, C.; Robson, M.; Iyengar, N.
    Medicine and Science in Sports and Exercise (2022)

    Fulltext@MSK | Save
  • Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Wang, R.; Singh, J. C.; Wong, S. T. L.; Lake, D.; Iyengar, N. M.; D'Andrea, G.; Brockway-Marchello, J. P.; Kaba, A.; Traina, T. A.; Robson, M. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • The optimal living and survivorship program: Piloting a novel cancer survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Clayton, J.; Smith, A.; Keenan, K.; Robson, M.; Iyengar, N.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • The optimal living and survivorship program: Piloting a novel survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Clayton, J.; Kelly, B.; Smith, A.; Keenan, K.; Robson, M. E.; Iyengar, N. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The optimal living and wellness program: Piloting a novel survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Smith, A.; Kelly, B.; Clayton, J.; Stein, B.; Keenan, K.; Robson, M. E.; Iyengar, N. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save